PMID: 9187444Jan 1, 1997Paper

Hodgkin's disease: complications of therapy and excess mortality

Annals of Oncology : Official Journal of the European Society for Medical Oncology
R T Hoppe

Abstract

The long-term survival of patients treated for Hodgkin's disease permits careful evaluation of long-term complications and excess mortality. Between 1960 and 1995, 2498 patients who were treated for Hodgkin's disease at Stanford University were evaluated. Survival, freedom from relapse, and important complications of therapy (cardiac disease and secondary cancers) were analyzed, and risk of mortality from all causes was calculated utilizing absolute excess risk calculations. The risk of death from Hodgkin's disease is 17% at 15 years of follow-up and increases only slightly thereafter. The risk of death from other causes is also 17% at 15 years, but increases sharply thereafter. The major causes of mortality (other than Hodgkin's disease) are secondary cancers and cardiac disease. Second cancers with significant increase in risk include leukemia (acute nonlymphocytic), non-Hodgkin's lymphoma, lung/pleural cancer, breast cancer, melanoma, soft tissue and bone sarcomas, stomach cancer, salivary gland tumors, thyroid cancer, and pancreatic cancer. The absolute excess risk of death from causes other than Hodgkin's disease increases during each five-year follow-up interval for at least 25 years. However, the absolute excess risk of ...Continue Reading

Citations

Aug 5, 2000·International Journal of Radiation Oncology, Biology, Physics·C K LeeM E Nierengarten
Jun 29, 2001·International Journal of Radiation Oncology, Biology, Physics·Z LiaoJ D Cox
Jun 29, 2001·International Journal of Radiation Oncology, Biology, Physics·A K NgJ C Weeks
Jan 5, 2002·International Journal of Radiation Oncology, Biology, Physics·Matthew C HullMark E Colgan
Dec 31, 2002·International Journal of Radiation Oncology, Biology, Physics·Gregory M ChronowskiJames D Cox
Jun 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Editha A KruegerLori J Pierce
Dec 17, 2002·Critical Reviews in Oncology/hematology·M Jacob AdamsSteven E Lipshultz
Aug 3, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P YounL B Travis
Sep 16, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aileen B ChenAndrea K Ng
Jan 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael Zach KoontzRanjana H Advani
Nov 2, 2011·The Oncologist·Ari M VanderWalde, Arti Hurria
Mar 16, 2011·Cardiology Research and Practice·Syed Wamique YusufIyad N Daher
Mar 21, 2013·International Journal of Clinical Oncology·Eiji KozawaYoshihiro Nishida
Oct 17, 2015·Expert Review of Anticancer Therapy·Timothy H DoriusJames O Armitage
Sep 23, 2014·Expert Opinion on Drug Delivery·Christopher M Knapp, Kathryn A Whitehead
Oct 3, 2007·Hematology/oncology Clinics of North America·Berthe M P Aleman, Flora E van Leeuwen
Jun 15, 2010·The Lancet Oncology·Paul LoriganNick Thatcher
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea K NgLois B Travis
Jan 9, 2019·Journal of the American Heart Association·Negareh MousaviRon Blankstein
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Ola LandgrenLois B Travis
Oct 11, 2008·Annals of Hematology·Dominic FongAlexandar Tzankov
Nov 9, 2017·American Journal of Hematology·Ana C XavierLuciano J Costa
Jan 24, 2009·International Journal of Cancer. Journal International Du Cancer·Anne AnderssonBeatrice Malmer
Nov 2, 2018·Cardio-Oncology·Michael Jacob AdamsThomas A Pearson
Jan 5, 2006·Journal of the National Cancer Institute·Lois B TravisMark H Greene
Feb 13, 2008·British Journal of Cancer·A AnderssonB Malmer
Feb 8, 2007·Journal of the National Cancer Institute·Anthony J SwerdlowDavid C Linch
Sep 6, 2017·Radiation Research·Stephanie PuukilaNeelam Khaper
Nov 23, 2006·Blood·Berthe M P AlemanFlora E van Leeuwen
Nov 28, 2001·Hematology·J M ConnorsS J Horning
Aug 4, 2009·The Oncologist·Stephen D Smith, John W Sweetenham
Oct 6, 2005·Journal of the National Cancer Institute·Lois B TravisMitchell H Gail
Feb 14, 2004·European Journal of Haematology·Heli PennanenTaina Turpeenniemi-Hujanen
Jul 11, 2000·British Journal of Haematology·A C Aisenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery
M ChelloA R Marchese
Radiation Protection Dosimetry
M RosemannM J Atkinson
Cytopathology : Official Journal of the British Society for Clinical Cytology
F AndreiuoloP Vielh
The Journal of Otolaryngology
Gerhard F HuberJoseph C Dort
© 2021 Meta ULC. All rights reserved